To investigate whether BRD7 can inhibit NPC growth and immune escape in vivo, we established a xenograft tumor model in nude mice for in vivo experiments and applied adoptive T cell therapy to tumor-bearing mice (Figure 6A, Figure S5A). This evidence concerns the gene BRD7 and nasopharyngeal carcinoma.